Clinical Trials Directory

Trials / Unknown

UnknownNCT04316949

Predictors of Respiratory Failure in SARS-Cov-2 Infection

Predictors of Respiratory Failure Requiring ICU Admission Among Hospitalized Patients With SARS-Cov-2 Infection

Status
Unknown
Phase
Study type
Observational
Enrollment
350 (estimated)
Sponsor
University of Bologna · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The emergence of SARS-CoV-2 is currently engaging and consuming most of resources of efficient healthcare systems in Europe, and several hospitals are currently experiencing a shortage of ICU beds for critically-ill patients with SARS-CoV-2 pneumonia. A risk stratification based on clinical, radiological and laboratory parameters seems necessary in order to better identify those patients who may need ICU admission and/or those who may benefit from a prompt antiviral therapy

Detailed description

The study will compared patients with and without respiratory failure in order to find risk factors for need for ICU admission. A simple score based on risk factors will be created from a multicenter Italian cohort and validated in a multicenter international cohort.

Conditions

Timeline

Start date
2020-03-20
Primary completion
2020-04-30
Completion
2020-05-31
First posted
2020-03-20
Last updated
2020-04-07

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04316949. Inclusion in this directory is not an endorsement.

Predictors of Respiratory Failure in SARS-Cov-2 Infection (NCT04316949) · Clinical Trials Directory